These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1963015)

  • 1. Once-daily dosing of enoxaparin (a low molecular weight heparin) in prevention of deep vein thrombosis after total hip replacement.
    Planès A; Vochelle N; Fagola M; Bellaud M; Feret J; Salzard C; Planès M
    Acta Chir Scand Suppl; 1990; 556():108-15. PubMed ID: 1963015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enoxaparin prophylaxis in elective hip surgery.
    Turpie AG
    Acta Chir Scand Suppl; 1990; 556():103-7. PubMed ID: 1963014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of postoperative venous thrombosis: a randomized trial comparing unfractionated heparin with low molecular weight heparin in patients undergoing total hip replacement.
    Planes A; Vochelle N; Mazas F; Mansat C; Zucman J; Landais A; Pascariello JC; Weill D; Butel J
    Thromb Haemost; 1988 Dec; 60(3):407-10. PubMed ID: 2853459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
    Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of deep vein thrombosis with low molecular-weight heparin in patients undergoing total hip replacement. A randomized trial. The German Hip Arthroplasty Trial (GHAT) Group.
    Arch Orthop Trauma Surg; 1992; 111(2):110-20. PubMed ID: 1314065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention of deep vein thrombosis by enoxaparin after total hip prosthesis].
    Vochelle N; Planes A
    Agressologie; 1990 Mar; 31(3):145-8. PubMed ID: 2173435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin.
    Leyvraz PF; Bachmann F; Hoek J; Büller HR; Postel M; Samama M; Vandenbroek MD
    BMJ; 1991 Sep; 303(6802):543-8. PubMed ID: 1655136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of thromboembolic disease in general surgery with enoxaparin (Clexane).
    Samama M; Combe S
    Acta Chir Scand Suppl; 1990; 556():91-5. PubMed ID: 1963022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety. Enoxaparin Clinical Trial Group.
    Colwell CW; Spiro TE; Trowbridge AA; Morris BA; Kwaan HC; Blaha JD; Comerota AJ; Skoutakis VA
    J Bone Joint Surg Am; 1994 Jan; 76(1):3-14. PubMed ID: 8288662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of a perioperative enoxaparin regimen in total hip replacement under various anesthesias.
    Planès A; Vochelle N; Fagola M; Bellaud M; Féret J; Salzard C; Planès M
    Am J Surg; 1991 Apr; 161(4):525-31. PubMed ID: 1852135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of enoxaparin in prevention of deep venous thrombosis in hip and knee surgery--a comparison with the dihydroergotamine-heparin combination.
    Perhoniemi V; Vuorinen J; Myllynen P; Kivioja A; Lindevall K
    Ann Chir Gynaecol; 1996; 85(4):359-63. PubMed ID: 9014067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of deep vein thrombosis after elective hip surgery. A randomized trial comparing low molecular weight heparin with standard unfractionated heparin.
    Levine MN; Hirsh J; Gent M; Turpie AG; Leclerc J; Powers PJ; Jay RM; Neemeh J
    Ann Intern Med; 1991 Apr; 114(7):545-51. PubMed ID: 1848054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of enoxaparin to prevent deep venous thrombosis after hip replacement surgery. Enoxaparin Clinical Trial Group.
    Spiro TE; Johnson GJ; Christie MJ; Lyons RM; MacFarlane DE; Blasier RB; Tremaine MD
    Ann Intern Med; 1994 Jul; 121(2):81-9. PubMed ID: 8017740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-molecular-weight heparin (enoxaparin) vs dextran 70. The prevention of postoperative deep vein thrombosis after total hip replacement. The Danish Enoxaparin Study Group.
    Arch Intern Med; 1991 Aug; 151(8):1621-4. PubMed ID: 1714709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of deep vein thrombosis after hip replacement--comparison between two low-molecular heparins, tinzaparin and enoxaparin.
    Planès A; Samama MM; Lensing AW; Büller HR; Barre J; Vochelle N; Beau B
    Thromb Haemost; 1999 Jan; 81(1):22-5. PubMed ID: 10348714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fixed combinations of low-molecular weight or unfractionated heparin plus dihydroergotamine in the prevention of postoperative deep vein thrombosis.
    Kakkar VV; Stringer MD; Hedges AR; Parker CJ; Welzel D; Ward VP; Sanderson RM; Cooper D; Kakkar S
    Am J Surg; 1989 Apr; 157(4):413-8. PubMed ID: 2539025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of a low-molecular-weight heparin (Kabi 2165) versus adjusted-dose subcutaneous standard heparin in the prophylaxis of deep-vein thrombosis after elective hip surgery.
    Dechavanne M; Ville D; Berruyer M; Trepo F; Dalery F; Clermont N; Lerat JL; Moyen B; Fischer LP; Kher A
    Haemostasis; 1989; 19(1):5-12. PubMed ID: 2537787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin/dihydroergotamine for venous thrombosis prophylaxis: comparison of low-dose heparin and low molecular weight heparin in hip surgery.
    Lassen MR; Borris LC; Christiansen HM; Møller-Larsen F; Knudsen VE; Boris P; Nehen AM; de Carvalho A; Jurik AG; Nielsen BW
    Br J Surg; 1988 Jul; 75(7):686-9. PubMed ID: 2843255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of deep vein thrombosis after total hip replacement. The effect of low-molecular-weight heparin with spinal and general anaesthesia.
    Planès A; Vochelle N; Fagola M; Feret J; Bellaud M
    J Bone Joint Surg Br; 1991 May; 73(3):418-22. PubMed ID: 1670442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of deep-vein thrombosis and pulmonary embolism after total hip replacement. Comparison of low-molecular-weight heparin and unfractionated heparin.
    Eriksson BI; Kälebo P; Anthymyr BA; Wadenvik H; Tengborn L; Risberg B
    J Bone Joint Surg Am; 1991 Apr; 73(4):484-93. PubMed ID: 2013587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.